Physician-owned "Ketanetics" Makes Revolutionary Treatment For Depression And Chronic Pain Available Nationally

Apr 07, 2014, 10:00 ET from Ketanetics, LLC

BOSTON, April 7, 2014 /PRNewswire/ -- Ketanetics, LLC, a Massachusetts-based company founded by physicians, is expanding the Ketamine infusion centers it operates beyond Massachusetts and New York.

Ketamine is a synthetic molecule that has shown extraordinary antidepressant activity in research trials, sometimes within just hours, and has performed better than ECT in one limited study conducted at the Johns Hopkins School of Medicine. It is delivered by IV, during a simple, 45-minute visit to a Ketanetics physician's office.The company was co-founded by Keith Ablow, MD, the famed psychiatrist, Fox News Contributor and assistant professor at Tufts Medical School, who said, "This may be the most powerful new tool we have had to address major depression and chronic pain in over a decade."

Ketanetics has locations in New York and Boston and expects its Miami location to open shortly. Ketamine can also relieve symptoms of chronic pain like that from trigeminal neuralgia, fibromyalgia and reflex sympathetic dystrophy—sometimes, permanently. The company is identifying internal medicine doctors, family physicians and anesthesiologists to license its Optimized Ketamine Therapy and deploy the system within their existing offices.

"Ketamine infusions are a remarkable advance in the treatment of chronic pain and treatment-resistant depression," said Glen Brooks, MD, an anesthesiologist trained at Harvard's Brigham & Women's Hospital, and one of the founders of Ketanetics. "As one of the first doctors in the world to use ketamine therapeutically, I am in a unique position to bring it to other physician practices."

Guy Navarra, MD, another co-founder, stated, "Ketanetics makes it possible for doctors to build their practices substantially while very substantially improving the lives of patients."

According to CEO Mark Donovan, the company is in the process of identifying doctors around the country who wish to integrate Ketanetics' "Optimized Ketamine Therapy" into their practices. "What we're offering doctors," Donovan said, "is the chance to harness the expertise of true ketamine experts, to join a network of healers dedicated to using this phenomenal technology in a 'best practices' manner."


Ronn Torossian 

SOURCE Ketanetics, LLC